The drug's active ingredient, tirzepatide, is marketed as Zepbound for weight loss and Mounjaro as a diabetes treatment
October 17, 2025: As of mid-October, the federal MDL for Mounjaro and other GLP-1 drugs counts 2,809 active lawsuits
The gap between expectations and clinical reality comes down to three things most guides never mention: lipotropic compounds don't burn fat independently, timing relative to GLP-1 therapy matters significantly, and methylation pathway function varies genetically by up to 40% between individuals
For those who cared for them, the situation is personal
Mary's Hospital Sleep Questionnaire , and the Stanford Sleepiness Scale , which are all well-known and empirically validated metrics for measuring sleep quality
I ate real, whole foodsincluding dairy and legumes